3Wald N F,Kennard A,Hackshaw A K.Firsttrimester serum screening for Down 's syndrome.Prenat Diagn,1995,15(13):1227-1240.
4Qin Q P,Christiansen M,Nguyen T H,et al.Schwangerschaftsprotein 1 (SP1) as maternalserum marker for Down's syndrome in first and second trimester.Prenat Diagn,1997,17(2):101-108.
5Wenstrom K,Owen J,Boo ts L.Second trimester maternalserum CA-125 versus estrio l in the multip lemarker screeningtest fo rDown syndrome.Obstet Gyneco l,1999,89:359-363.
6Stenhouse E J,Crossley J A,Aitken D A,et al.Firsttrimestercombined ultrasound and biochemical screening for Down syndrome in routine clinical practice[J].Prenat Diagn,2004,24.
7Wald N J,Rodeck C,Hackshaw A K,et al.SURUSS in per2spective[J].B J Obstet Gynecol,2004,111(6):521-531.
5Boorrnans EM, Birnie E, Wildschut HI, et al. Multiplex ligation- dependent probe amplification vel~us karyotyping in prenatal diag- nosis: the M. A. K. E. study[ J ]. BMC Pregnancy Childbirth, 2008, 8:18.
6Price JO, Elias S, Wachtel SS, et al. Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytornetry [J]. ArnJ Obstet Gynecol,1991,165(6 Pt 1 ) :1731-1737.
7Zheng YL, Zhen DK, Farina A, et al. Fetal cell identifiers : results of microscope slide-based immunocytochemical studies as a function of gestational age and abnormality [ J ]. Am J Obstet Gynecol, 1999,180 ( 5 ) : 1234 -1239.
8Wachtel SS, Sammons, Manley, et al. Fetal ceils in maternal blood: recovery by charge flow separation[J]. Hum Genet, 1996, 98 (2) : 162-166.
9Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in materna/ plasma and serum [J]. Lancet, 1997, 350 (9076) : 485-487.
10Chan KC, Zhang J, Hui AB, et al. Size distributions of maternal and fetal DNA in maternal plasma[J]. Clin Chern, 2004,50( 1 ) :88-92.